Randomized controlled trial of sulforaphane and metabolite discovery in children with autism Spectrum disorder
Gracia Wynne Duncan regarding not only our own experience with GLP-1 agonist drugs for weight loss (specifically Semaglutide) - but also reviewing the pros and cons, the history and possible future of these drugs, and everything that you might need to know in order to make an educated decision about whether this might be a good choice for you
For instance, if injecting weekly, use the right abdomen one week, left abdomen the next, then right thigh, left thigh, and so forth
[DOI] [PMC free article] [PubMed] [Google Scholar] 125.Ta N., Jiang X., Zhang Y., Wang H
PLOS ONE 6 , e24710 (2011)
Additional ASCO GI 2026 analyses focused on adenoma recurrence, a validated surrogate endpoint in colorectal cancer prevention research